Deal Announcements

ImaginAb Banks Series B Venture Capital Funding

Monday, May 12, 2014 5:45:00 AM PDT | VentureDeal

   Inglewood, California  --  Medical device technology company ImaginAb has secured $21 million in its second round of institutional venture capital investment.

ImaginAb reengineers therapeutic antibodies against targets into small proteins optimized for diagnostic imaging of cancers and autoimmune diseases.

Investors in the round were led by Merieux Developpment and included Novartis Venture Fund, Cycad Group and Nextech Invest.

The company said it would use the funding proceeds to accelerate the development of its lead program in prostate cancer, IAB2M.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1